These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2361002)

  • 1. Modulation of the B-A transition of DNA by potential antitumor antibiotics. Influence of the base composition of DNA.
    Fritzsche H; Rupprecht A
    J Biomol Struct Dyn; 1990 Apr; 7(5):1135-40. PubMed ID: 2361002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-DNA sequence-dependent interactions analysed by electric linear dichroism.
    Bailly C; Hénichart JP; Colson P; Houssier C
    J Mol Recognit; 1992 Dec; 5(4):155-71. PubMed ID: 1339484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infrared linear dichroism studies of DNA-drug complexes: quantitative determination of the drug-induced restriction of the B-A transition.
    Fritzsche H
    Nucleic Acids Res; 1994 Mar; 22(5):787-91. PubMed ID: 8139919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intercalation of daunomycin into stacked DNA base pairs. DFT study of an anticancer drug.
    Barone G; Guerra CF; Gambino N; Silvestri A; Lauria A; Almerico AM; Bickelhaupt FM
    J Biomol Struct Dyn; 2008 Aug; 26(1):115-30. PubMed ID: 18533732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator binding.
    Bachur NR; Johnson R; Yu F; Hickey R; Applegren N; Malkas L
    Mol Pharmacol; 1993 Nov; 44(5):1064-9. PubMed ID: 8246909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanics and molecular dynamics studies of the intercalation of dynemicin-A with oligonucleotide models of DNA.
    Cardozo MG; Hopfinger AJ
    Mol Pharmacol; 1991 Dec; 40(6):1023-8. PubMed ID: 1758437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of sequence-specific DNA binding ligands that use a two-stranded peptide motif for DNA sequence recognition.
    Nikolaev VA; Grokhovsky SL; Surovaya AN; Leinsoo TA; Sidorova NYu ; Zasedatelev AS; Zhuze AL; Strahan GA; Shafer RH; Gursky GV
    J Biomol Struct Dyn; 1996 Aug; 14(1):31-47. PubMed ID: 8877560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of lambda cro repressor with synthetic operator OR3 studied by competition binding with minor groove binders.
    Gursky GV; Surovaya AN; Kurochkin AV; Chernov BK; Volkov SK; Kirpichnikov MP
    J Biomol Struct Dyn; 1992 Aug; 10(1):15-33. PubMed ID: 1329842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of the antitumor drug nogalamycin to bulged DNA structures.
    Caceres-Cortes J; Wang AH
    Biochemistry; 1996 Jan; 35(2):616-25. PubMed ID: 8555235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probes for double helical DNA sequence information: molecular mechanics study of a proposed model.
    Shea RG; Hopkins PB; Olson AJ
    J Biomol Struct Dyn; 1987 Oct; 5(2):313-26. PubMed ID: 3271477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence polarization studies of the binding of BMS 181176 to DNA.
    Krishnan BS; Moore ME; Lavoie CP; Long BH; Dalterio RA; Wong HS; Rosenberg IE
    J Biomol Struct Dyn; 1994 Dec; 12(3):625-36. PubMed ID: 7727062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electric linear dichroism as a new tool to study sequence preference in drug binding to DNA.
    Colson P; Bailly C; Houssier C
    Biophys Chem; 1996 Jan; 58(1-2):125-40. PubMed ID: 8679916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of distamycin and netropsin analogues.
    Xie G; Gupta R; Lown JW
    Anticancer Drug Des; 1995 Jul; 10(5):389-409. PubMed ID: 7639929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of drug binding on DNA flexibility: a normal mode analysis.
    Ha Duong T; Zakrzewska K
    J Biomol Struct Dyn; 1997 Jun; 14(6):691-701. PubMed ID: 9195338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA recognition by intercalators and hybrid molecules.
    Waring MJ; Bailly C
    J Mol Recognit; 1994 Jun; 7(2):109-22. PubMed ID: 7826671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the entropic structural transition of DNA complexes formed with intercalating drugs.
    Rocha MS
    Phys Biol; 2009 Jun; 6(3):036013. PubMed ID: 19525574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: various DNA binding geometry and interesting antitumor capacity.
    Zhang Z; Yang Y; Zhang D; Wang Y; Qian X; Liu F
    Bioorg Med Chem; 2006 Oct; 14(20):6962-70. PubMed ID: 16828559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential scanning calorimetric study of the effect of intercalators and other kinds of DNA-binding drugs on the stepwise melting of plasmid DNA.
    Maeda Y; Nunomura K; Ohtsubo E
    J Mol Biol; 1990 Sep; 215(2):321-9. PubMed ID: 1698988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intercalative binding compared to external binding on Z/B equilibrium of poly d(GMe5C) using fluorescent oxazolopyridocarbazoles as probes.
    Le Ber P; Schwaller MA; Auclair C
    J Mol Recognit; 1989 Dec; 2(4):152-7. PubMed ID: 2637042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrared linear dichroism of oriented DNA-ligand complexes prepared with the wet-spinning method.
    Fritzsche H; Rupprecht A; Richter M
    Nucleic Acids Res; 1984 Dec; 12(23):9165-77. PubMed ID: 6096820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.